NL187352B - Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat. - Google Patents
Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat.Info
- Publication number
- NL187352B NL187352B NLAANVRAGE8202064,A NL8202064A NL187352B NL 187352 B NL187352 B NL 187352B NL 8202064 A NL8202064 A NL 8202064A NL 187352 B NL187352 B NL 187352B
- Authority
- NL
- Netherlands
- Prior art keywords
- oxoalkanol
- derivative
- acid ester
- sulfonic acid
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
- C07C245/14—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/18—Saturated compounds containing keto groups
- C07C62/24—Saturated compounds containing keto groups the keto group being part of a ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7853081 | 1981-05-22 | ||
| JP7853081A JPS57193444A (en) | 1981-05-22 | 1981-05-22 | Sulfonate derivative, its preparation and antilipemic agent containing the same |
| JP21295081 | 1981-12-29 | ||
| JP21295081A JPS58135850A (ja) | 1981-12-29 | 1981-12-29 | トランス−１−（ベンゼンスルホニルオキシ）−２−シクロヘキシル−２−エタノン誘導体及びこれを含有する抗脂血症剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8202064A NL8202064A (nl) | 1982-12-16 |
| NL187352B true NL187352B (nl) | 1991-04-02 |
| NL187352C NL187352C (nl) | 1991-09-02 |
Family
ID=26419587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE8202064,A NL187352C (nl) | 1981-05-22 | 1982-05-19 | Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4452813A (nl) |
| KR (1) | KR880002298B1 (nl) |
| AU (1) | AU536817B2 (nl) |
| CA (1) | CA1189082A (nl) |
| CH (1) | CH649079A5 (nl) |
| DE (1) | DE3219244C2 (nl) |
| ES (2) | ES8401754A1 (nl) |
| FR (1) | FR2509297A1 (nl) |
| GB (1) | GB2101124B (nl) |
| IT (1) | IT1157013B (nl) |
| NL (1) | NL187352C (nl) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3368259D1 (en) * | 1982-09-06 | 1987-01-22 | Taiho Pharmaceutical Co Ltd | Sulfonic ester derivatives and process for their preparation |
| US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CA2551037A1 (en) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Novel piperidine derivative |
| US7829552B2 (en) | 2003-11-19 | 2010-11-09 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyromimetics |
| US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
| KR20070084455A (ko) * | 2004-11-23 | 2007-08-24 | 워너-램버트 캄파니 엘엘씨 | 지질혈증 치료용 ｈｍｇ ｃｏ-ａ 환원효소 억제제로서의7-(2ｈ-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체 |
| RU2417985C2 (ru) | 2005-05-30 | 2011-05-10 | Баниу Фармасьютикал Ко., Лтд. | Новые производные пиперидина |
| US20100216758A1 (en) | 2005-08-10 | 2010-08-26 | Makoto Ando | Pyridone Compounds |
| JPWO2007024004A1 (ja) | 2005-08-24 | 2009-03-05 | 萬有製薬株式会社 | フェニルピリドン誘導体 |
| EP1939194A4 (en) | 2005-09-07 | 2010-12-08 | Banyu Pharma Co Ltd | AROMATIC SUBSTITUTED BICYLIC PYRIDONE DERIVATIVE |
| JP2009512715A (ja) | 2005-10-21 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| CA2627139A1 (en) | 2005-10-27 | 2007-05-03 | Banyu Pharmaceutical Co., Ltd. | Novel benzoxathiin derivative |
| EP1953165B1 (en) | 2005-11-10 | 2012-02-01 | Msd K.K. | Aza-substituted spiro derivative |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| CA2664358A1 (en) | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | Diarylketimine derivative |
| TW200831497A (en) * | 2006-10-12 | 2008-08-01 | Epix Delaware Inc | Carboxamide compounds and their use |
| JP5498168B2 (ja) | 2006-12-01 | 2014-05-21 | ブリストル−マイヤーズ スクイブ カンパニー | アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体 |
| EP2145884B1 (en) | 2007-04-02 | 2014-08-06 | Msd K.K. | Indoledione derivative |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
| WO2009076404A1 (en) * | 2007-12-10 | 2009-06-18 | Epix Delaware, Inc. | Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| JP2011506466A (ja) | 2007-12-11 | 2011-03-03 | 株式会社サイトパスファインダー | カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用 |
| WO2009110510A1 (ja) | 2008-03-06 | 2009-09-11 | 萬有製薬株式会社 | アルキルアミノピリジン誘導体 |
| JPWO2009119726A1 (ja) | 2008-03-28 | 2011-07-28 | Ｍｓｄ株式会社 | メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体 |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| AU2009261248A1 (en) | 2008-06-19 | 2009-12-23 | Banyu Pharmaceutical Co., Ltd. | Spirodiamine-diarylketoxime derivative |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| JPWO2010013595A1 (ja) | 2008-07-30 | 2012-01-12 | Ｍｓｄ株式会社 | ５員−５員又は５員−６員縮環シクロアルキルアミン誘導体 |
| CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
| US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
| WO2011106273A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| WO2011145022A1 (en) | 2010-05-21 | 2011-11-24 | Pfizer Inc. | 2-phenyl benzoylamides |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2826649C (en) | 2011-02-25 | 2016-07-26 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| US20130345392A1 (en) | 2011-03-04 | 2013-12-26 | Pfizer Inc | Edn3-like peptides and uses thereof |
| US20140045746A1 (en) | 2012-08-02 | 2014-02-13 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| BR112015019836A2 (pt) | 2013-02-22 | 2017-07-18 | Merck Sharp & Dohme | composto, composição farmacêutica, e, uso de um composto |
| US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体 |
| CN113388007A (zh) | 2013-06-05 | 2021-09-14 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| EP3186242B1 (en) | 2014-08-29 | 2021-10-06 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| EP3526199B1 (en) | 2016-10-14 | 2022-04-13 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| EP3558298A4 (en) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | ANTIDIABETIC SPIROCHROMAN COMPOUNDS |
| CN113302189A (zh) | 2018-11-20 | 2021-08-24 | Tes制药有限责任公司 | α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂 |
| JOP20210193A1 (ar) | 2019-01-18 | 2023-01-30 | Astrazeneca Ab | مثبطات pcsk9 وطرق استخدامها |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4411911A (en) * | 1980-01-31 | 1983-10-25 | Taiho Pharmaceutical Company, Limited | Method of treating hyperlipidemia and inflammation with sulfonate derivatives |
-
1982
- 1982-05-11 US US06/377,074 patent/US4452813A/en not_active Expired - Fee Related
- 1982-05-13 AU AU83679/82A patent/AU536817B2/en not_active Ceased
- 1982-05-19 NL NLAANVRAGE8202064,A patent/NL187352C/nl not_active IP Right Cessation
- 1982-05-20 IT IT67661/82A patent/IT1157013B/it active
- 1982-05-21 FR FR8208888A patent/FR2509297A1/fr active Granted
- 1982-05-21 CH CH3165/82A patent/CH649079A5/de not_active IP Right Cessation
- 1982-05-21 GB GB08214826A patent/GB2101124B/en not_active Expired
- 1982-05-21 CA CA000403485A patent/CA1189082A/en not_active Expired
- 1982-05-21 DE DE3219244A patent/DE3219244C2/de not_active Expired
- 1982-05-21 ES ES513184A patent/ES8401754A1/es not_active Expired
- 1982-05-22 KR KR8202253A patent/KR880002298B1/ko active
-
1983
- 1983-05-12 ES ES83522317A patent/ES522317A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| KR880002298B1 (ko) | 1988-10-22 |
| IT8267661A0 (it) | 1982-05-20 |
| IT1157013B (it) | 1987-02-11 |
| KR830010060A (ko) | 1983-12-24 |
| GB2101124A (en) | 1983-01-12 |
| ES513184A0 (es) | 1984-01-01 |
| NL187352C (nl) | 1991-09-02 |
| CA1189082A (en) | 1985-06-18 |
| DE3219244A1 (de) | 1982-12-09 |
| US4452813A (en) | 1984-06-05 |
| DE3219244C2 (de) | 1986-06-05 |
| CH649079A5 (de) | 1985-04-30 |
| GB2101124B (en) | 1985-05-01 |
| AU8367982A (en) | 1982-11-25 |
| ES8406426A1 (es) | 1984-08-16 |
| AU536817B2 (en) | 1984-05-24 |
| ES522317A0 (es) | 1984-08-16 |
| FR2509297A1 (fr) | 1983-01-14 |
| NL8202064A (nl) | 1982-12-16 |
| ES8401754A1 (es) | 1984-01-01 |
| FR2509297B1 (nl) | 1984-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL187352C (nl) | Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat. | |
| ES513221A0 (es) | Un procedimiento para la preparacion de derivados de acidos alcanoicos. | |
| NL930074I2 (nl) | Gesubstitueerde pyridylsulfinylbenzimidazolen met maagzuurafscheidingseigenschappen, farmaceutische preparaten, die deze verbindingen bevatten en tussenprodukten voor de bereiding ervan. | |
| DE3669104D1 (de) | Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten. | |
| NL192561B (nl) | Oogontstekings-werende middelen. Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten. | |
| NL191754B (nl) | Farmaceutisch preparaat tegen acne. | |
| DE3872937D1 (de) | Benzoylaminophenoxybuttersaeure-derivate. | |
| FI822187A0 (fi) | Farmaceutiska preparat | |
| NL950027I2 (nl) | Alfa-halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat die dit bevat. | |
| NL188645C (nl) | 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
| NL192741B (nl) | Oxazafosforin-4-thioalkaanzuurverbindingen en farmaceutisch preparaat met antineoplastische eigenschappen. | |
| NL191575C (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat. | |
| NL7900264A (nl) | 4-pyridon-3-carbonzuurderivaten alsmede de bereiding ervan. | |
| FI874382A0 (fi) | Farmaceutiska preparat. | |
| ES510232A0 (es) | Un procedimiento para la preparacion de complejos de acidos grasos-anfoteros. | |
| ATE16806T1 (de) | 3-methylflavon-8-carboxylsaeureester. | |
| NO884361L (no) | Katechol-karboksylsyrederivater. | |
| NL7701641A (nl) | Werkwijze voor de bereiding van een cyclo- propaancarbonzuurester. | |
| NL930014I2 (nl) | 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat. | |
| NL193023B (nl) | Indolylalkaanzuurderivaat, alsmede geneesmiddel met ontstekingsremmende werking. | |
| BE888528A (nl) | Isoftaalzuurpycolylamidemonohydraat, werkwijze voor de bereinding daarvan en farmaceutische toepassing, | |
| NL7900721A (nl) | Nieuwe derivaten van 1-naftylazijnzuur, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze verbindingen bevatten. | |
| DE3689702T2 (de) | Dihydrolysergsäureester. | |
| DE3768557D1 (de) | Trans-hexahydroterephthalsaeureesterderivate. | |
| NL7808440A (nl) | Anti-inflammatoire 1-fenylethanolamine-derivaten, far- maceutische preparaten, die deze verbindingen bevatten en werkwijzen ter bereiding daarvan. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| V1 | Lapsed because of non-payment of the annual fee |
Effective date: 19961201 |